Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHARCOT study of single-dose denosumab in acute Charcot foot
2016-003594-17Phase 2Active
- Sponsor
- AMC Health
- Start
- Nov 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Charcot neuroarthropathy (CN) comparing Denosumab with Placebo (2 arms). Primary endpoint: Time to cessation of total contact cast boot with fracture healing. Started Nov 2016; status: active.
02
Drugs
denosumab
03
Conditions
Charcot neuroarthropathy (CN)
Beyond the preview
Go deeper on 2016-003594-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003594-17.